Shopping Cart
Remove All
Your shopping cart is currently empty
(Z)-KC02 is an ABHD16A inhibitor which targets the enzyme responsible for producing lysophosphatidylserine (lyso-PS), a lipid involved in regulating immune and neurological functions. This compound is linked to the mitigation of neurological disorders, including retinitis pigmentosa and cataracts (PHARC), by depleting lyso-PS in lymphoblasts from affected individuals. Moreover, (Z)-KC02 diminishes lyso-PS levels and lipopolysaccharide-induced cytokine production in macrophages and influences lyso-PS metabolism in vivo [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 μg | $159 | 35 days | 35 days | |
| 500 μg | $663 | 35 days | 35 days | |
| 1 mg | $1,080 | 35 days | 35 days |
| Description | (Z)-KC02 is an ABHD16A inhibitor which targets the enzyme responsible for producing lysophosphatidylserine (lyso-PS), a lipid involved in regulating immune and neurological functions. This compound is linked to the mitigation of neurological disorders, including retinitis pigmentosa and cataracts (PHARC), by depleting lyso-PS in lymphoblasts from affected individuals. Moreover, (Z)-KC02 diminishes lyso-PS levels and lipopolysaccharide-induced cytokine production in macrophages and influences lyso-PS metabolism in vivo [1]. |
| In vitro | (Z)-KC02 disrupts ABHD16A in murine macrophages, thereby reducing lyso-PS levels [1]. |
| Molecular Weight | 287.35 |
| Formula | C17H21NO3 |
| Cas No. | 1646795-60-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.